MedPath

Effects of Melatonin Supplementation on Sleep Quality in Breast Cancer Patients

Phase 3
Recruiting
Conditions
Condition 1: Sleep Quality. Condition 2: Breast Cancer.
Sleep disorders
Malignant neoplasm of breast
Registration Number
IRCT20240304061164N1
Lead Sponsor
Sabzevar University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
54
Inclusion Criteria

Informed consent to participate in the study.
Patients with breast cancer under follow-up who have been treated for three months based on pathology results and were disease-free at the time of examination.
People without diabetes, high blood pressure, cardiovascular diseases, kidney disease, liver disease, acute diseases, autoimmune disease, thyroid disorder, mental disorders

Exclusion Criteria

Patients with known underlying diseases including uncontrolled diabetes, uncontrolled high blood pressure, cardiovascular diseases, chronic kidney disease, chronic liver disease, autoimmune disease, thyroid disorder, and the use of uncontrolled psychiatric drugs.
Unwillingness to continue cooperation in the project
Diagnosis of metastasis
Causing severe toxicities that could not be controlled with usual doses, such as nausea

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath